Results
7
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
7 companies
Zylox-Tonbridge Medical Technology
Market Cap: HK$7.9b
A medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally.
2190
HK$24.30
7D
0%
1Y
86.9%
MicroTech Medical (Hangzhou)
Market Cap: HK$3.4b
Provides diabetes management, diabetes treatment, and diabetes monitoring medical devices in China and internationally.
2235
HK$8.07
7D
5.1%
1Y
91.7%
New Horizon Health
Market Cap: HK$6.3b
An investment holding company, engages in the research and development of screening products for colorectal, cervical, and other types of cancer in the People’s Republic of China.
6606
HK$14.14
7D
0%
1Y
-52.3%
Adicon Holdings
Market Cap: HK$4.9b
An investment holding company, provides medical testing services in the People’s Republic of China.
9860
HK$6.85
7D
0.3%
1Y
-25.5%
Yidu Tech
Market Cap: HK$7.0b
An investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People’s Republic of China, Brunei, Singapore, and internationally.
2158
HK$6.60
7D
14.8%
1Y
75.5%
Angelalign Technology
Market Cap: HK$10.8b
An investment holding company, researches and designs, manufactures, sells, and markets clear aligner treatment solutions in the People’s Republic of China and internationally.
6699
HK$63.00
7D
-2.2%
1Y
-16.6%
YSB
Market Cap: HK$7.4b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$10.92
7D
23.8%
1Y
38.9%